Literature DB >> 11164901

Beneficial immune activity after CNS injury: prospects for vaccination.

M Schwartz1, G Moalem.   

Abstract

A recent study in our laboratory showed, against all expectations, that macrophages and a particular type of T cell, by promoting regrowth and reducing the post-traumatic spread of damage in the injured rat optic nerve or spinal cord, have a beneficial effect on the injured CNS. Macrophages in the CNS have long been thought to have predominantly destructive effects. Autoimmunity in general, and in the CNS in particular, has never been documented as a purposeful physiological response of benign character. Our results suggest that after traumatic injury to the central nervous system (CNS), both of these immune cell types potentially have beneficial effects: macrophages can promote repair and T cells of a particular specificity can reduce the spread of damage. However, possibly because of the immune-privileged character of the CNS, the spontaneously evoked physiological activities of both macrophages and T cells in the CNS are restricted, and appear to need well-controlled boosting in order to be effective. It thus appears that (i) a stress signal transmitted from the traumatized tissue (in this case the CNS) for recruitment of the adaptive immune system does not have to be pathogen-related in order to evoke a response, (ii) a response to self is not necessarily a quirk of nature, and (iii) an autoimmune response, provided that it is well-regulated, helps the individual to cope with stress signals from the traumatized CNS, and thus plays a role in maintenance of the injured tissue without posing a threat to the organism.

Entities:  

Mesh:

Year:  2001        PMID: 11164901     DOI: 10.1016/s0165-5728(00)00447-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

1.  Loss of cholinergic phenotype in septohippocampal projection neurons: relation to brain versus peripheral IL-2 deficiency.

Authors:  Danielle M Meola; Zhi Huang; Michael King; John M Petitto
Journal:  Neurosci Lett       Date:  2013-02-13       Impact factor: 3.046

Review 2.  Glucocorticoids and central nervous system inflammation.

Authors:  Klaus Dinkel; William O Ogle; Robert M Sapolsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Stroke induces a rapid adaptive autoimmune response to novel neuronal antigens.

Authors:  Sterling B Ortega; Ibrahim Noorbhai; Katie Poinsatte; Xiangmei Kong; Ashley Anderson; Nancy L Monson; Ann M Stowe
Journal:  Discov Med       Date:  2015-05       Impact factor: 2.970

4.  A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.

Authors:  Tobias Goldmann; Peter Wieghofer; Philippe F Müller; Yochai Wolf; Diana Varol; Simon Yona; Stefanie M Brendecke; Katrin Kierdorf; Ori Staszewski; Moumita Datta; Tom Luedde; Mathias Heikenwalder; Steffen Jung; Marco Prinz
Journal:  Nat Neurosci       Date:  2013-09-29       Impact factor: 24.884

Review 5.  Traumatic optic neuropathy: a review.

Authors:  Arjunan Muthu Kumaran; Gangadhara Sundar; Lim Thiam Chye
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-11-25

6.  Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner.

Authors:  Kosara Smiljanic; Irena Lavrnja; Aleksandra Mladenovic Djordjevic; Sabera Ruzdijic; Mirjana Stojiljkovic; Sanja Pekovic; Selma Kanazir
Journal:  Histochem Cell Biol       Date:  2010-06-18       Impact factor: 4.304

7.  Immunodeficiency impairs re-injury induced reversal of neuronal atrophy: relation to T cell subsets and microglia.

Authors:  Grace K Ha; Zhi Huang; Ravi Parikh; Marlon Pastrana; John M Petitto
Journal:  Exp Neurol       Date:  2007-08-01       Impact factor: 5.330

Review 8.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

Review 9.  Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.

Authors:  Melissa Bowerman; Thierry Vincent; Frédérique Scamps; Florence E Perrin; William Camu; Cédric Raoul
Journal:  Front Cell Neurosci       Date:  2013-11-19       Impact factor: 5.505

10.  Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke.

Authors:  Li Qian; Lin Yuanshao; Huang Wensi; Zhou Yulei; Chen Xiaoli; Wang Brian; Zhang Wanli; Cai Zhengyi; Xue Jie; Zhang Wenhui; Yu Tieer; Wang Hong; He Jincai; Jin Kunlin; Shao Bei
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.